openPR Logo
Press release

Portland Monthly Honors Dr. Dennis Cozzocrea as a Top Doctor in Chiropractic for 2025

02-11-2025 07:50 PM CET | Sports

Press release from: ABNewswire

Portland Monthly Honors Dr. Dennis Cozzocrea as a Top Doctor

Dr. Dennis Cozzocrea of Gentle Chiro has been honored as a Portland Monthly Top Doctor 2025 for his excellence in chiropractic care. With 35 years of experience, he specializes in diversified adjustments, NUCCA, activator technique, and extremity adjusting. A lifelong learner, he has attended over 50 seminars to stay ahead in his field. A Veteran and community supporter, Dr. Cozzocrea is dedicated to helping patients live pain-free, healthier lives.
Portland, OR - Gentle Chiro is proud to announce that Dr. Dennis Cozzocrea has been recognized as a Portland Monthly Top Doctor for 2025 in the field of chiropractic care. This prestigious award highlights Dr. Cozzocrea's expertise, dedication, and significant contributions to the chiropractic profession.

With 35 years of experience, Dr. Cozzocrea has developed a multifaceted approach to chiropractic care, mastering techniques such as diversified adjustments, extremity adjusting, activator technique, and NUCCA. His commitment to continuous learning has led him to attend over 50 seminars, ensuring he remains at the forefront of advancements in chiropractic treatment.

"I believe lifelong learning is essential in our industry," says Dr. Cozzocrea. "Staying up to date with the latest research and techniques allows me to provide the best possible care for my patients and help them live pain-free, healthier lives."

Beyond his clinical expertise, Dr. Cozzocrea is deeply involved in the Portland community. As a Veteran, he is passionate about giving back and actively supports LGBTQ+ charities. His dedication to both his patients and the community further sets him apart as a leader in his field.

The Portland Monthly Top Doctors award is a significant recognition, celebrating medical professionals who go above and beyond in their specialties. Dr. Cozzocrea's selection reaffirms his exceptional patient care, skill, and commitment to chiropractic excellence.

For those seeking top-tier chiropractic care, Gentle Chiro offers a compassionate and skilled approach tailored to individual needs. To schedule an appointment with Dr. Cozzocrea, visit gentlechiro.com [https://gentlechiro.com/] or call (503) 512-9591.

About Gentle Chiro:

Gentle Chiro is a leading chiropractic clinic in Portland, OR, specializing in holistic, patient-centered care. Led by Dr. Dennis Cozzocrea, the clinic provides advanced chiropractic treatments designed to promote long-term health and well-being.

Media Contact
Company Name: Gentle Chiro
Contact Person: Jared Urbach
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=portland-monthly-honors-dr-dennis-cozzocrea-as-a-top-doctor-in-chiropractic-for-2025]
Phone: (503) 512-9591
Address:8905 SW Nimbus Ave Ste 140
City: Beaverton
State: OR
Country: United States
Website: https://gentlechiro.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Portland Monthly Honors Dr. Dennis Cozzocrea as a Top Doctor in Chiropractic for 2025 here

News-ID: 3863417 • Views:

More Releases from ABNewswire

Free Self Assessment UK | File Taxes Online with Pie
Free Self Assessment UK | File Taxes Online with Pie
Pie is making tax season easier with its free self assessment UK tool, giving taxpayers the ability to file online with HMRC in minutes. From freelancers to side hustlers, Pie helps users avoid costly mistakes while ensuring compliance all without the heavy fees of traditional accountants. LONDON, United Kingdom - 23 September, 2025 - With more than 12 million self assessment tax returns filed each year, UK taxpayers are searching for
Best Digital Tax App UK | HMRC-Ready Filing with Pie
Best Digital Tax App UK | HMRC-Ready Filing with Pie
Pie is fast becoming recognised as the best digital tax app in the UK. With HMRC-ready submissions, real-time calculations, and an interface designed for simplicity, Pie is helping freelancers, landlords, and small businesses take control of their taxes. LONDON, United Kingdom - 23 September, 2025 - As more people turn to mobile-first solutions for money management, Pie is gaining recognition as the best digital tax app in the UK, combining simplicity,
Atopic Dermatitis Pipeline Drugs Report 2025 by DelveInsight Highlighting Current Clinical Trials, Emerging Drug Classes, and Market Opportunities
Atopic Dermatitis Pipeline Drugs Report 2025 by DelveInsight Highlighting Curren …
DelveInsight's "Atopic Dermatitis Pipeline Insight 2025" report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the Atopic Dermatitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Atopic Dermatitis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Download our comprehensive report now
Breast Cancer Pipeline Drugs Report 2025 by DelveInsight Covering Evolving Research, Therapeutic Innovations, and Competitive Developments Across the Pharma Sector
Breast Cancer Pipeline Drugs Report 2025 by DelveInsight Covering Evolving Resea …
DelveInsight's "Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 250+ Breast Cancer companies and 300+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest

All 5 Releases